Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 5663 of 5804
-
New imaging agent aims to light up Hard-to-Find cancers
Diagnosis TerminatedThis is a single arm, pilot trial that evaluates the ability of a novel imaging agent (111In-ABD147) to detect metastatic cancer in participants with solid tumors. 111In-ABD147 is a high affinity Delta-like ligand 3 (DLL3) antigen binding domain fused to an engineered humanized F…
Phase: EARLY_PHASE1 • Sponsor: Thomas Hope • Aim: Diagnosis
Last updated Jun 27, 2026 12:24 UTC
-
Radioactive pill tested in healthy men to map huntington Drug's path
Knowledge-focused Not yet recruitingThis is a phase 1, single-center, single-dose, open-label mass-balance study to evaluate radioactive recovery rate, radioactive PK characteristics, metabolite identification, and to observe the safety in healthy male subjects of \[14C\] LPM3770164.
Phase: PHASE1 • Sponsor: Luye Pharma Group Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC
-
Healthy men test new drug copycat in early safety study
Knowledge-focused Not yet recruitingThe study is being conducted to compare the pharmacokinetic (PK) parameters of HLX319 and EU-Phesgo® after a single subcutaneous administration in healthy male subjects in China, providing a basis for the design of subsequent clinical study protocols.
Phase: PHASE1 • Sponsor: Shanghai Henlius Biotech • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:02 UTC
-
Drug interaction check: how does itraconazole change HS-10506 levels?
Knowledge-focused Not yet recruitingA single-center, open-label, fixed-sequence, self-controlled phase I clinical trial aimed at evaluating the effect of itraconazole capsules(CYP3A inhibitor) on the pharmacokinetics of HS-10506 tablets in healthy participants.
Phase: PHASE1 • Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:09 UTC
-
New drug ABBV-722 put through interaction tests in healthy volunteers
Knowledge-focused OngoingThe objective of this study is to assess the effect of repeated doses of ABBV-722 on the single dose pharmacokinetics (PK) of Midazolam, Digoxin, Pitavastatin, Metformin, and Sitagliptin
Phase: PHASE1 • Sponsor: AbbVie • Aim: Knowledge-focused
Last updated Jul 22, 2026 00:00 UTC
-
Can smartphone apps make nursing students better at catheter insertion?
Knowledge-focused ENROLLING_BY_INVITATIONThe aim of this study is to evaluate the effects of a Learning Paths and vodcast-supported teaching method on nursing students' knowledge levels, clinical skills, and learning motivation regarding urinary catheter insertion.
Phase: NA • Sponsor: Necmettin Erbakan University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Healthy volunteers needed to test drug interactions
Knowledge-focused CompletedResearchers want to learn about ulonivirine when given with atorvastatin and metformin in healthy people. The goal of this study is to compare the amount of atorvastatin and metformin in a person's body over time when given with and without ulonivirine.
Phase: PHASE1 • Sponsor: Merck Sharp & Dohme LLC • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
No best way to remove breathing tubes? study surveys Real-World practices.
Knowledge-focused Not yet recruitingExtubation is a delicate and complex phase of airway management in anesthesia and critical care. A variety of complications are of concern, ranging from transient hypoxemia to the need for reintubation, which can then become life-threatening for the patient. For this procedure, …
Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
New lung drug ENV-101 put through safety checks in healthy volunteers
Knowledge-focused Recruiting nowThe purposes of this study are to: 1. evaluate potential interactions between taladegib (ENV-101) and current standard-of-care (SOC) therapies for idiopathic pulmonary fibrosis (IPF), including nintedanib and pirfenidone, and 2. more fully characterize the pharmacokinetics (PK) …
Phase: PHASE1 • Sponsor: Endeavor Biomedicines, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:34 UTC
-
New drug BW-20805-2 put to the test in healthy volunteers
Knowledge-focused Not yet recruitingA Phase 1 Clinical Study Of BW-20805-2-1001 in Healthy Participants
Phase: PHASE1 • Sponsor: Shanghai Argo Biopharmaceutical Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
New drug HXN6005 tested in healthy volunteers for first time
Knowledge-focused Recruiting nowThe goal of this clinical trial is to evaluate the safety, tolerability, pharmacokinetic characteristics and pharmacodynamics of HXN6005 in Healthy Participants. Researchers will compare HXN6005 to a placebo (a look-alike substance that contains no drug). Participants will take…
Phase: PHASE1 • Sponsor: Helixon Biotechnology (Suzhou) Co., Ltd • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Healthy women needed to compare two tablet versions of experimental drug
Knowledge-focused Recruiting nowThis study aims to compare the PK of Navlimetostat after administration of a wet-granulation tablet versus the dry-granulation tablet formulation in healthy adult female
Phase: PHASE1 • Sponsor: Bristol-Myers Squibb • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
New drug BLKR201 put to the test in healthy volunteers
Knowledge-focused Recruiting nowThe goal of this clinical trial is to learn if BLKR201 is safe in healthy adults. Researchers will also learn how the body absorbs and processes BLKR201 and how food may affect it. The main questions this study aims to answer are: * Is BLKR201 safe and well tolerated when taken…
Phase: PHASE1 • Sponsor: Formation Bio, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:25 UTC
-
New oximeter software put to the test in small study
Knowledge-focused CompletedThe clinical use of pulse oximeters has reduced the frequency and necessity of invasive arterial blood sampling and has helped to improve patient safety by providing continuous information to clinicians about patients' oxygenation status. all.health is dedicated to developing and…
Sponsor: All Health, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
Can nurse Know-How prevent bedsores from medical devices?
Knowledge-focused Not yet recruitingThis multicenter, scenario-based cross-sectional study aims to examine the effect of operating room nurses' knowledge of medical device-related pressure injuries on their clinical decision-making skills. The study will be conducted with approximately 165 operating room nurses wor…
Sponsor: University of Gaziantep • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC
-
Disaster drill survey aims to boost emergency response skills
Knowledge-focused OngoingThe purpose of this study is to determine students' perceptions of and following a planned mass casualty simulation. Primary Aim: To determine students' perceptions on teamwork, communication, confidence, and what students learned.
Sponsor: Youngstown State University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:26 UTC
-
Massive record review aims to boost sports medicine care
Knowledge-focused OngoingTo use existing standard-of-care documentation in a sports medicine electronic medical record (EMR) to evaluate patient characteristics, interventions delivered, utilization management, and clinical outcomes in routine sports medicine care, in order to generate evidence to improv…
Sponsor: ATI Holdings, LLC • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
New drug BI 3821001 begins first human safety tests
Knowledge-focused Recruiting nowThe main objectives of this trial are to investigate safety, tolerability and pharmacokinetics (PK) of BI 3821001 in healthy male trial participants.
Phase: PHASE1 • Sponsor: Boehringer Ingelheim • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:25 UTC
-
New drug HS-20152 tested in healthy people for first time
Knowledge-focused Not yet recruitingThis first-in-human, randomized, double-blind, placebo-controlled, single ascending dose study will evaluate the safety and tolerability of HS-20152, an investigational therapy targeting the complement pathway, in healthy adults. Secondary objectives include characterization of p…
Phase: PHASE1 • Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:02 UTC
-
New drug vicadrostat put to the heart test in healthy volunteers
Knowledge-focused OngoingThe main objective of this trial is to investigate the effect of vicadrostat on the heart compared with placebo in healthy male and female volunteers.
Phase: PHASE1 • Sponsor: Boehringer Ingelheim • Aim: Knowledge-focused
Last updated Jul 09, 2026 00:00 UTC